Author | Lightnews

Reposted by Izabela Zakrocka

Vikram Paralkar @paralkarlab.bsky.social · 11h

Congratulations @ksusztak.bsky.social and Gerd Blobel (not on Bluesky)!!!

PennMedCSO @pennmedcso.bsky.social · 13h

Congratulations to the 3 @pennmedicine.bsky.social honorees elected to the National Academy of Medicine! Election to @nam.edu is considered one of the highest honors in the field of health & medicine. Check back this week as we profile each new member tinyurl.com/ysjzdrbk

1 2 8

Reposted by Izabela Zakrocka

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 1d

Perfect find pubmed.ncbi.nlm.nih.gov/39836391/

Any comments @christosargyrop.bsky.social

Effectiveness of Empagliflozin vs Dapagliflozin for Kidney Outcomes in Type 2 Diabetes - PubMed

The results of this cohort study suggest that people with type 2 diabetes who initiated treatment with empagliflozin and dapagliflozin had comparable long-term kidney outcomes.

pubmed.ncbi.nlm.nih.gov

1 3 4

Reposted by Izabela Zakrocka

Nephrology Journal Club @nephjc.bsky.social · 1d

Last #NephJC short on individual data meta-analysis showing that although we love flozins for their extensive benefits we actually don’t completely understand how they work #Nephsky

✍️Meta by @willkidney.bsky.social & co
📝 Write up by @nephroseeker.medsky.social

www.nephjc.com/news/2025/10...

Empagliflozin, the kidney, and what we still don’t understand — NephJC

NephJC short on an empagliflozin meta-analysis

www.nephjc.com

1 6 9

Reposted by Izabela Zakrocka

Joel Topf @kidneyboy.bsky.social · 1d

New episode of Freely Filtered with @brendonneuen.bsky.social @hswapnil.medsky.social @captainchloride.bsky.social @sophia-kidney.bsky.social and author Muth Vaduganathan discussing the CONVINCE trial

www.nephjc.com/freelyfilter...

With chapters, refs, and pictures

4 7

Reposted by Izabela Zakrocka

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 2d

Obinituzumab aka ‘Obi’ is now FDA approved for lupus nephritis

finance.yahoo.com/news/fda-app...

#lupus

FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis

SOUTH SAN FRANCISCO, Calif., October 20, 2025--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Gazyva...

finance.yahoo.com

1 16 32

Reposted by Izabela Zakrocka

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 3d

the filtrate @freelyfiltered.bsky.social listening raptly to Mike Walsh tell us about the events unfolding as ACHIEVE achieved futility
@kidneyboy.bsky.social @medpeedskidneys.bsky.social

#nephsky

2 2 11

Reposted by Izabela Zakrocka

Cristina Popa @nephroseeker.medsky.social · 3d

📅 Coming next week, October 23, 2025, at 5:00 PM (CEST) #Nephsky #Medsky

✨E-seminar: Interventional Nephrology- A Beginner’s Guide for Young Nephrologists

🎙️Presenting @drbarbateba.bsky.social
💬Moderator @hugodiniz.medsky.social

👉You can register here
www.era-online.org/video-pages/...

Interventional Nephrology: A Beginner’s Guide for Young Nephrologists | ERA

Register for the YNP e-Seminar on Interventional Nephrology: A Beginner’s Guide for Young Nephrologists.

www.era-online.org

1 6 12

Reposted by Izabela Zakrocka

Joel Topf @kidneyboy.bsky.social · 4d

How long until drug labels stop including the Cockcroft-Gault Equation?

Here is Zyrica's (pregabalin) label

2 2 11

Reposted by Izabela Zakrocka

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 6d

Nephrology is becoming like Oncology in this respect!

2 5

Reposted by Izabela Zakrocka

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · 6d

The opening plenary at #KidneyWk looks phenomenal

Renal RCT Renaissance is upon us

(LBCT list drops tomorrow)

www.asn-online.org/education/ki...

program for thursday at kidney wk

including 2 LBCTs and Vlado P talking on RCTs and curing kidney disease

2 12 19

Reposted by Izabela Zakrocka

Arkana Labs @arkanalabs.bsky.social · 8d

Cholesterol emboli involving the kidney may manifest clinically as acute kidney injury, hematuria, proteinuria (both non-nephrotic and nephrotic range), and even new onset hypertension.

#TeachingPoints #kidneypath #renal #pathology #nephx #pathx

1 2 8

Reposted by Izabela Zakrocka

Juan Carlos Q Vélez, MD @juancarlosqvelez.bsky.social · 14d

When asked by a denier about what proof I have that #UrineMicroscopy makes a difference (often w/a “I’ve been practicing 30 yrs without it”), my answer is that one cannot grasp the full extent of missed information by ignoring a tool when there’s lack of proficiency on how to properly use the tool

1 4

Reposted by Izabela Zakrocka

NEJM.org @nejm.org · 17d

A 52-year-old woman with hypertension presented with fatigue, vomiting, and confusion. Examination was notable for powdery, crystalline deposits on the arms, legs, trunk, and scalp. Read the full case details: nej.md/4pKf6tL

#MedSky #DermSky #Nephrology

Images in Clinical Medicine
Uremic Frost

Photos of the patient's right arm and left leg

2 12

Reposted by Izabela Zakrocka

Tobias_B_Huber @tobias-b-huber.bsky.social · 23d

Hamburg News: Study by Jan Czogalla & @puellesv.bsky.social & collaborators introduces a metabolically enhanced buffer + perfusion technique - opening a new avenue for kidney transplant organ preservation. @isgd.bsky.social

JCI insight @insight.jci.org · 23d

A technical advance in the field of organ transplantation!

@tobias-b-huber.bsky.social & team develop a metabolite-enhanced perfusion solution that improves kidney transplant viability, testing it across various species, including humans:
buff.ly/FyKsRiE

1 2 2

Reposted by Izabela Zakrocka

Arkana Labs @arkanalabs.bsky.social · 23d

Thank you to @nephrowhitt.bsky.social, @juancarlosqvelez.bsky.social, and Dr. Vandana Niyyar for joining @nephrosharma.bsky.social, @glombandit.bsky.social, for this vital conversation.

#nephsky #renalsky #kidneypath

Glom Goals: Why Adequacy Matters

Glom Goals · Episode

open.spotify.com

3 3

Reposted by Izabela Zakrocka

Arkana Labs @arkanalabs.bsky.social · 23d

How did the frequency of inadequate renal biopsies go from <1% in 2004 up to 27% in 2025?

Listen to our podcast for more insight on this crisis: youtu.be/GSUhu9ysNyM?...

#renal #kidneypath #nephsky #renalsky #nephrology

1 3 5

Reposted by Izabela Zakrocka

Healthcare-Global @healthcare-global.bsky.social · Sep 22

www.euractiv.com/news/poland-...

Poland boosts access to new therapies with record reimbursements | Euractiv

So far this year, Poland has extended reimbursement to 151 new therapies, the highest figure ever recorded

www.euractiv.com

1 5

Reposted by Izabela Zakrocka

European Society of Cardiology @escardio.bsky.social · Aug 29

NEW Focused update of the 2019 #ESCGuidelines on #dyslipidaemias : bit.ly/4fVz6F4

#lipids #riskfactors #cvprev

1 7 11

Reposted by Izabela Zakrocka

Joel Topf @kidneyboy.bsky.social · Aug 27

I've never seen this figure or sentiment before. But it makes me want to vomit. The intro and discussion are the least important parts of the paper. Methods rule. Results are meaningless without clear and logical methods. If a mentor suggests this, find a better mentor.

x.com/acagamic/sta...

Tweet that says:

Most papers fail because they fight the shape of good research writing.

The best research papers shrink problems and expand implications.

The middle of your paper should feel tight. Not sprawling.

No one cares about your method...
Until you make them care about the problem.

Your goal here: Make the reader feel smarter, not lost.

This paper funnel isn’t optional.

It’s the invisible hand behind every great paper.

Every part of your paper should feel inevitable.

Confused readers are readers that don't cite your work.

Structure fixes that.

diagram of a research manuscript. I presume the wider the slide the more words it gets and the more important it is, but the idea here is that the intro, discussion, and conclusion deserve the most words and attention while methods and results get little attention.

9 5 24

Reposted by Izabela Zakrocka

Eric Topol @erictopol.bsky.social · Aug 28

Your DNA sequence reveals a rare mutation. Will you get the disease, i.e. penetrance? A new study using machine learning predicts this across 10 common diseases, 1,600 genomic variants
New @science.org
science.org/doi/10.1126/...

6 34 110

Izabela Zakrocka @izabelazakrocka.bsky.social · Aug 20

Something for @nephrowhitt.bsky.social and co. 😎

Reposted by Izabela Zakrocka

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · Aug 20

The CPC from last @ahascience.bsky.social #HypertensionSessions now published in @ahajournals.bsky.social

www.ahajournals.org/doi/10.1161/...

thanks to @drjmluther.bsky.social and all the education editors for the invite

We hope it makes for an educational read!

3 7 12

Reposted by Izabela Zakrocka

Michael Walsh @lastwalsh.bsky.social · Aug 19

Following #ACHIEVE our meta-analysis of RCTs of MRAs for pts receiving dialysis in @thelancet.com. Thanks to @lonniepyne.bsky.social for leading. No signal for benefit among low-risk of bias RCTs and a good demo of why we continue to need large simple trials.
www.sciencedirect.com/science/arti...

Safety and efficacy of steroidal mineralocorticoid receptor antagonists in patients with kidney failure requiring dialysis: a systematic review and meta-analysis of randomised controlled trials

Mineralocorticoid receptor antagonists can prevent cardiovascular events in patients with heart failure and non-severe chronic kidney disease, but the…

www.sciencedirect.com

3 12

Reposted by Izabela Zakrocka

Swapnil Hiremath 🍁🇨🇦 @hswapnil.medsky.social · Aug 18

More on Hydra-ANCA-zine

Four cases, and review of previous (~ 169) cases reported in the literature

academic.oup.com/ckj/article-... in @ckj-era.bsky.social

#NephSky #Hydralazine

Hydralazine-induced antineutrophil cytoplasmic antibody-associated glomerulonephritis

Antineutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN) can lead to multi-organ failure and death [1, 2]. As an antihypertensive medica

academic.oup.com

1 4 10

Reposted by Izabela Zakrocka

Hans-Joachim Anders @hjanders.bsky.social · Aug 16

Now open access in @ndt-era.bsky.social

Anti-nephrin, anti-podocin and anti-Kirrel1 antibodies: Biological challenges and clinical implications

🧐 Clinical implementation of anti-slit diaphragm antibody testing = precision dx and tx in podocytopathies

▶️ academic.oup.com/ndt/article/...

8 18